Literature DB >> 16918823

Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link?

J-F Huang1, W-L Chuang, C-Y Dai, C-K Ho, S-J Hwang, S-C Chen, Z-Y Lin, L-Y Wang, W-Y Chang, M-L Yu.   

Abstract

BACKGROUND AND OBJECTIVES: Virus hepatitis may lead to nephropathy as one of its multiple extrahepatic manifestations. Proteinuria by dipstick, a simple test in practice, is a useful and cardinal sign of underlying renal abnormalities. The aim of this study was to elucidate the impact of hepatitis B virus (HBV) and/or hepatitis C virus (HCV) infections on the occurrence of proteinuria amongst adults. DESIGN AND
SETTING: A prospective, cross-sectional, community-based study was conducted in an HBV/HCV endemic area of southern Taiwan. Eligible subjects aged 40-65 years (n=9934) underwent testing of hepatitis B surface antigen (HBsAg), HCV antibody (anti-HCV) and other related biochemical profiles. Urinalysis with repeated dipstick for proteinuria detection was performed.
RESULTS: Anti-HCV-positive rate amongst proteinuria subjects was significantly higher than nonproteinuria subjects (9.6% vs. 6.2%, P<0.001). By contrast, HBsAg-positive rate did not differ between subjects with and without proteinuria (13.0% vs. 13.8%, P=0.57). Prevalence of proteinuria amongst anti-HCV-positive subjects (10.2%) was significantly higher than that in HBsAg-positive subjects (6.4%, P=0.004) and in HBsAg-negative or anti-HCV-negative subjects (7.0%, P=0.004). The difference persisted even after excluding diabetics. Multivariate logistic regression analyses showed that diabetes was the most important significant factor associated with proteinuria, followed by hypertension, anti-HCV seropositivity, body mass index, age and triglyceride levels.
CONCLUSION: We demonstrated the significant association between proteinuria and HCV, but not HBV, infection in this HBV/HCV-endemic area.

Entities:  

Mesh:

Year:  2006        PMID: 16918823     DOI: 10.1111/j.1365-2796.2006.01686.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  25 in total

Review 1.  Hepatitis C virus infection and kidney disease: a meta-analysis.

Authors:  Fabrizio Fabrizi; Paul Martin; Vivek Dixit; Piergiorgio Messa
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-08       Impact factor: 8.237

Review 2.  Management of patients with hepatitis C infection and renal disease.

Authors:  Chalermrat Bunchorntavakul; Monthira Maneerattanaporn; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2015-02-27

3.  Association of H. pylori infection with chronic kidney disease among Chinese adults.

Authors:  Xianglei Kong; Dayu Xu; Feng Li; Xiaojing Ma; Hong Su; Dongmei Xu
Journal:  Int Urol Nephrol       Date:  2017-01-02       Impact factor: 2.370

4.  KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2018-09-19

Review 5.  Extrahepatic manifestations of chronic hepatitis C virus infection.

Authors:  Patrice Cacoub; Cloe Comarmond; Fanny Domont; Léa Savey; Anne C Desbois; David Saadoun
Journal:  Ther Adv Infect Dis       Date:  2016-02

6.  Thyroid autoantibodies and dysfunction do not impact the treatment efficacy of peginterferon and ribavirin combination therapy in chronic hepatitis C.

Authors:  Jee-Fu Huang; Chao-Kuan Huang; Ming-Lung Yu; Chia-Yen Dai; Chung-Feng Huang; Wei-Wen Hung; Ming-Lun Yeh; Meng-Hsuan Hsieh; Jeng-Fu Yang; Ming-Yen Hsieh; Zu-Yau Lin; Shinn-Chern Chen; Shun-Sheng Wu; Wan-Long Chuang
Journal:  Hepatol Int       Date:  2011-08-18       Impact factor: 6.047

7.  Hyperhomocysteinemia increases the risk of chronic kidney disease in a Chinese middle-aged and elderly population-based cohort.

Authors:  Xianglei Kong; Xiaojing Ma; Chengyin Zhang; Hong Su; Dongmei Xu
Journal:  Int Urol Nephrol       Date:  2016-11-07       Impact factor: 2.370

8.  Risk factors for proteinuria in HIV-infected and -uninfected Hispanic drug users.

Authors:  Martin S Rhee; Christopher H Schmid; Lesley A Stevens; Janet E Forrester
Journal:  Am J Kidney Dis       Date:  2008-06-24       Impact factor: 8.860

Review 9.  Hepatitis C virus associated glomerulopathies.

Authors:  Abdullah Ozkok; Alaattin Yildiz
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

10.  Factors associated with CKD in the elderly and nonelderly population.

Authors:  Ming-Yen Lin; Yi-Wen Chiu; Chien-Hung Lee; Hui-Yen Yu; Hung-Chun Chen; Ming-Tsang Wu; Shang-Jyh Hwang
Journal:  Clin J Am Soc Nephrol       Date:  2012-10-18       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.